155 related articles for article (PubMed ID: 8603417)
1. Measurement of potential doubling time for human tumor xenografts using the cytokinesis-block method.
Hlatky L; Olesiak M; Hahnfeldt P
Cancer Res; 1996 Apr; 56(7):1660-3. PubMed ID: 8603417
[TBL] [Abstract][Full Text] [Related]
2. Estimation of the dividing fraction and potential doubling time of tumors using cytochalasin B.
Shibamoto Y; Streffer C
Cancer Res; 1991 Oct; 51(19):5134-8. PubMed ID: 1913638
[TBL] [Abstract][Full Text] [Related]
3. Proliferative activity and micronucleus frequency after radiation of lung cancer cells as assessed by the cytokinesis-block method and their relationship to clinical outcome.
Shibamoto Y; Ike O; Mizuno H; Fukuse T; Hitomi S; Takahashi M
Clin Cancer Res; 1998 Mar; 4(3):677-82. PubMed ID: 9533537
[TBL] [Abstract][Full Text] [Related]
4. Tamoxifen-induced increase in the potential doubling time of MCF-7 xenografts as determined by bromodeoxyuridine labeling and flow cytometry.
Sarkaria JN; Gibson DF; Jordan VC; Fowler JF; Lindstrom MJ; Mulcahy RT
Cancer Res; 1993 Sep; 53(18):4413-7. PubMed ID: 8364937
[TBL] [Abstract][Full Text] [Related]
5. Cell proliferation kinetics in human tumor xenografts measured with iododeoxyuridine labeling and flow cytometry: a study of heterogeneity and a comparison between different methods of calculation and other proliferation measurements.
Perez LA; Dombkowski D; Efird J; Preffer F; Suit HD
Cancer Res; 1995 Jan; 55(2):392-8. PubMed ID: 7812972
[TBL] [Abstract][Full Text] [Related]
6. The decreased influence of overall treatment time on the response of human breast tumor xenografts following prolongation of the potential doubling time (Tpot).
Sarkaria JN; Fowler JF; Lindstrom MJ; Jordan VC; Mulcahy RT
Int J Radiat Oncol Biol Phys; 1995 Feb; 31(4):833-40. PubMed ID: 7860396
[TBL] [Abstract][Full Text] [Related]
7. Comparison of BrdUrd and [3H]TdR incorporation to estimate cell proliferation, cell loss, and potential doubling time in tumor xenografts.
Zätterström UK; Johansson M; Källén A; Baldetorp B; Oredsson S; Wennerberg J; Killander D
Cytometry; 1992; 13(8):872-9. PubMed ID: 1459003
[TBL] [Abstract][Full Text] [Related]
8. Measuring potential doubling times of murine tumors using flow cytometry.
Carlton JC; Terry NH; White RA
Cytometry; 1991; 12(7):645-50. PubMed ID: 1782833
[TBL] [Abstract][Full Text] [Related]
9. Comparison of glutathione levels in rodent and human tumor cells grown in vitro and in vivo.
Allalunis-Turner MJ; Lee FY; Siemann DW
Cancer Res; 1988 Jul; 48(13):3657-60. PubMed ID: 3378208
[TBL] [Abstract][Full Text] [Related]
10. Establishment and cell cycle kinetics of a human squamous cell carcinoma in nude mice and in vitro.
Meck RA; Ingram M; Meck JM; McCullough JL; Wu MC; Yunis AA
Cancer Res; 1981 Mar; 41(3):1076-85. PubMed ID: 7193083
[TBL] [Abstract][Full Text] [Related]
11. Influence of sampling time on assessment of potential doubling time.
Høyer M; Bentzen SM; Salling LN; Overgaard J
Cytometry; 1994 Jun; 16(2):144-51. PubMed ID: 7924683
[TBL] [Abstract][Full Text] [Related]
12. Repopulation kinetics during fractionated irradiation and the relationship to the potential doubling time, Tpot.
Speke AK; Hill RP
Int J Radiat Oncol Biol Phys; 1995 Feb; 31(4):847-56. PubMed ID: 7860398
[TBL] [Abstract][Full Text] [Related]
13. [Clinical value of the potential doubling time (Tpot) measured by flow cytometry].
Dubray B; Maciorowsky Z; Cosset JM; Terry NH
Bull Cancer; 1995; 82(5):331-8. PubMed ID: 7626840
[TBL] [Abstract][Full Text] [Related]
14. Antitumor activity of troxacitabine (Troxatyl) against anthracycline-resistant human xenografts.
Gourdeau H; Genne P; Kadhim S; Bibeau L; Duchamp O; Ouellet F; deMuys JM; Bouffard DY; Attardo G
Cancer Chemother Pharmacol; 2002 Dec; 50(6):490-6. PubMed ID: 12451476
[TBL] [Abstract][Full Text] [Related]
15. Antitumor activity of ZD1694 (tomudex) against human head and neck cancer in nude mouse models: role of dosing schedule and plasma thymidine.
Cao S; McGuire JJ; Rustum YM
Clin Cancer Res; 1999 Jul; 5(7):1925-34. PubMed ID: 10430100
[TBL] [Abstract][Full Text] [Related]
16. Quantitative comparison between the transplantability of human and murine tumors into the brain of NCr/Sed-nu/nu nude and severe combined immunodeficient mice.
Taghian A; Budach W; Zietman A; Freeman J; Gioioso D; Suit HD
Cancer Res; 1993 Oct; 53(20):5018-21. PubMed ID: 8402693
[TBL] [Abstract][Full Text] [Related]
17. In vitro growth and drug sensitivity of tumor colony-forming units from human tumor xenografts.
Taetle R; Koessler AK; Howel SB
Cancer Res; 1981 May; 41(5):1856-60. PubMed ID: 7214353
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of flow cytometric methods for determining population potential doubling times using cultured cells.
Terry NH; White RA; Meistrich ML; Calkins DP
Cytometry; 1991; 12(3):234-41. PubMed ID: 2036917
[TBL] [Abstract][Full Text] [Related]
19. Preclinical antitumor efficacy of the polyamine analogue N1, N11-diethylnorspermine administered by multiple injection or continuous infusion.
Bernacki RJ; Oberman EJ; Seweryniak KE; Atwood A; Bergeron RJ; Porter CW
Clin Cancer Res; 1995 Aug; 1(8):847-57. PubMed ID: 9816054
[TBL] [Abstract][Full Text] [Related]
20. The effect of the overall treatment time of fractionated irradiation on the tumor control probability of a human soft tissue sarcoma xenograft in nude mice.
Allam A; Perez LA; Huang P; Taghian A; Azinovic I; Freeman J; Duffy M; Efird J; Suit HD
Int J Radiat Oncol Biol Phys; 1995 Apr; 32(1):105-11. PubMed ID: 7721606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
